Concord Biotech shares fell in Q2 FY27 despite strong revenue growth, as rising input costs and a changing product mix raised ...

In a post on X, Aashish Somaiyaa recalled the market pessimism of 2008, 2013, and 2020, warning investors against getting ...

Allied Blenders saw strong sales and record volumes, but declining margins raise concerns about supply-chain issues, rising ...

Mid-cap mutual funds have delivered better average returns than large-cap and flexi-cap funds over five and 10 years, ...

Shanghai Henlius Biotech Licenses Two TCE Products from Amberstone MT Sep. 23 Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products MT Sep. 23 Shanghai Henlius Biotech, Inc. And ...

The mid-cap segment, represented by the BSE MIDCAP 150 index, experienced a marginal decline of 0.11% on 28 Oct 2026, reflecting a cautious market mood amid mixed sectoral performances and uneven ...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings ...

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth ...

Low liquidity can make it difficult for investors to trade large volumes without affecting share prices, particularly when ...

The S&P/ASX Small Ordinaries Index (XSO) finished at 3,159.80, gaining 12.90 points or 0.41% in the latest session as ...

The stock market rally continued on Wall Street Tuesday as investors awaited Wednesday's Fed decision and a barrage of ...

Cerebras Systems ( CBRS +10.10%) charged sharply higher on Tuesday, climbing as much as 11.2%. By the time the market closed, ...